Free Trial

FibroGen (FGEN) SEC Filings & 10K Form

FibroGen logo
$0.33 -0.01 (-1.56%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.34 +0.00 (+0.48%)
As of 05/2/2025 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent FibroGen SEC Filings

DateFilerForm TypeView
04/25/2025
4:14 PM
FibroGen (Filer)
Form ARS
04/17/2025
4:00 PM
FibroGen (Filer)
Form PRE 14A
03/28/2025
4:20 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
8:00 AM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
8:00 AM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:15 PM
FibroGen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
6:01 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:02 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:03 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
4:19 PM
FibroGen (Filer)
Form 424B5
02/24/2025
4:22 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
6:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:49 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SCHEDULE 13G/A
02/13/2025
5:24 PM
FibroGen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SCHEDULE 13G/A
01/10/2025
5:15 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:16 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:01 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
8:15 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:52 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SC 13G/A
11/12/2024
1:33 PM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
11:11 AM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/03/2024
3:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:10 PM
FibroGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/10/2024
11:15 PM
FibroGen (Filer)
Form EFFECT
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
FibroGen (Subject)
Form SC 13G/A
06/28/2024
4:08 PM
FibroGen (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/26/2024
7:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:30 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
Adib Deyaa (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:37 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:12 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
7:00 PM
Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Set to Shock the World by May 1st ? (Ad)

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.

Click here now because after June 1st, it could be too late.
06/06/2024
7:00 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:00 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FGEN) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners